DRW Securities, LLC
Broker-DealerPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1481986
CHICAGO, IL
Position in TEVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$773,210
+$383,054 QoQ
Shares Held
25,671
+105.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DRW Securities, LLC holds $2,827,228 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
25,671 | $773,210 | |
| 2 | ALKS |
Alkermes plc.
|
20,180 | $713,564 | |
| 3 | VTRS |
Viatris Inc
|
26,173 | $353,597 | |
| 4 | PRGO |
PERRIGO Co plc
|
28,706 | $308,302 | |
| 5 | ZTS |
Zoetis Inc.
|
1,824 | $215,615 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
36,807 | $213,480 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
21,845 | $207,964 | |
| 8 | SNOA |
Sonoma Pharmaceuticals, Inc.
|
12,015 | $25,591 |
All Filings in TEVA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $773,210 | 25,671 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $390,156 | 12,501 | Shares | Other | 2026-02-12 | |
| 2025-09-30 | $355,600 | 17,604 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $231,824 | 13,832 | Shares | Other | 2025-08-14 | |
| 2022-03-31 | $174,428 | 18,576 | Shares | Other | 2022-05-12 | |
| 2020-06-30 | $132,140 | 10,717 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $96,238 | 10,717 | Shares | Other | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||